ARC Future Fellowships - Grant ID: FT0992210

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/API/grants/FT0992210

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Defining targets and generating tools/therapeutic agents for prevention, diagnosis and therapy of atherothrombosis. Atherosclerosis and its complications such as myocardial infarction and stroke are a major cause of death and disability in Australia and worldwide. The proposed research program investigates new therapeutic targets and concepts (e.g. targeting of stem cells) to treat atherosclerosis and aims to develop new therapeutic agents using modern biotechnological methods. The project further aims to develop nanoparticle-based diagnostic tools to identify and preventatively treat atherosclerotic plaques that are prone to cause myocardial infarction. The expected outcome will provide direct benefit to patients and create new economic opportunities in Australian bio-/nanotechnology.

Funded Activity Details

Start Date: 2010

End Date: 12-2013

Funding Scheme: ARC Future Fellowships

Funding Amount: $788,800.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biotechnology | Therapies And Therapeutic Technology | Cardiorespiratory Medicine and Haematology | Cardiology (Incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

Cardiovascular system and diseases | Diagnostics | Treatments (e.g. chemicals, antibiotics) |

Related Links